Pharmaceutical compositions of cabozantinib
US11679105B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2023 |
| Grant date | Jun 20, 2023 |
| Priority date | — |
| Expiry date | Feb 10, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions are provided, which comprise cabozantinib or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable excipient, wherein the inventive compositions exhibit enhanced bioavailability compared to the currently marketed or commercially available formulations. The present invention also provides manufacturing processes thereof and use of the said inventive compositions for the prevention, treatment or prophylaxis of disorders in human patients in need thereof. The present invention relates to oral pharmaceutical compositions of cabozantinib, methods for their administration, processes for their production, and use of these compositions for treatment of diseases treatable by cabozantinib.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.